A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies

Cynthia Ma, Sumithra J. Mandrekar, Steven R. Alberts, Gary A. Croghan, Aminah Jatoi, Joel M. Reid, Lorelei J. Hanson, Laura Bruzek, Angelina D. Tan, Henry C. Pitot, Charles Erlichman, John J. Wright, Alex A. Adjei

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds